Endothelial dysfunction is considered as an early change in atherogenesis. Raised levels of
systemic inflammatory markers are associated with cardiovascular disease (CVD). Endocan …

Endocan is a novel endothelium derived soluble dermatan sulfate proteoglycan. It has the
property of binding to a wide range of bioactive molecules associated with cellular signaling …

Endothelial dysfunction is regarded as the initial lesion in the development of
atherosclerosis. Endocan, previously called endothelial cell–specific molecule 1 (ESM-1), is …

Endothelial dysfunction is considered to be an early change in atherosclerosis. Endocan,
also known as endothelial cell specific molecule-1, is a soluble proteoglycan mainly …

Background Endocan is a novel human endothelial cell–specific molecule. The central role
of leukocytes and endothelial dysfunction in the development of Behçet disease (BD) led us …

Plasma endocan levels are elevated in a large number of diseases, and may reflect
endothelial cell dysfunction. There are currently no data on endocan in patients with chronic …

Background Psoriasis vulgaris is an inflammatory disease characterized by epidermal
hyperproliferation, leucocyte adhesion molecule expression and leucocyte infiltration …

Proteoglycans are a group of molecules that contain at least one glycosaminoglycan chain,
such as a heparan, dermatan, chondroitin, or keratan sulfate, covalently attached to the …

Chondroitin sulfate (CS) and dermatan sulfate (DS) are linear anionic polysaccharides that
are widely present on the cell surface and in the cell matrix and connective tissue. CS and …

The vascular endothelium is localized at the interface between the blood and surrounding
tissues, playing a pivotal role in the maintenance of tissue-fluid homeostasis and in the …